Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Shares Issued (2016 - 2025)

United Therapeutics (UTHR) has disclosed Shares Issued for 17 consecutive years, with $99.0 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 285.21% to $99.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $162.2 million through Dec 2025, up 6.36% year-over-year, with the annual reading at $173.9 million for FY2025, 14.03% up from the prior year.
  • Shares Issued hit $99.0 million in Q4 2025 for United Therapeutics, up from $40.2 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $99.0 million in Q4 2025 to a low of $2.8 million in Q1 2021.
  • Historically, Shares Issued has averaged $32.8 million across 5 years, with a median of $25.2 million in 2023.
  • Biggest five-year swings in Shares Issued: surged 1760.61% in 2023 and later crashed 88.39% in 2025.
  • Year by year, Shares Issued stood at $44.4 million in 2021, then rose by 25.0% to $55.5 million in 2022, then soared by 64.68% to $91.4 million in 2023, then plummeted by 71.88% to $25.7 million in 2024, then skyrocketed by 285.21% to $99.0 million in 2025.
  • Business Quant data shows Shares Issued for UTHR at $99.0 million in Q4 2025, $40.2 million in Q3 2025, and $18.1 million in Q2 2025.